Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access

NCT05124184 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05124184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access
Lead sponsor
W.L.Gore & Associates
Phase
Observational
Overall status
Completed
Start date
January 24, 2022
Completion date
July 22, 2024
Enrollment
356 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

aaa - abdominal aortic aneurysm, end-stage renal disease, pad - peripheral arterial disease